These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

245 related items for PubMed ID: 11378632

  • 1. Choice of lipid-regulating drugs.
    Med Lett Drugs Ther; 2001 May 28; 43(1105):43-8. PubMed ID: 11378632
    [No Abstract] [Full Text] [Related]

  • 2. Drugs for lipids.
    Treat Guidel Med Lett; 2005 Mar 28; 3(31):15-22. PubMed ID: 15726011
    [No Abstract] [Full Text] [Related]

  • 3. LDL = 5: Virtues and dangers of multidrug therapy of low-density lipoprotein cholesterol.
    Phillips W, Schaefer S.
    Prev Cardiol; 2010 Mar 28; 13(2):69-71. PubMed ID: 20377808
    [Abstract] [Full Text] [Related]

  • 4. [Lipid therapy in risk patients. Do we concentrate too much on LDL cholesterol?].
    März W.
    MMW Fortschr Med; 2005 Apr 07; 147(14):14. PubMed ID: 15887675
    [No Abstract] [Full Text] [Related]

  • 5. Effects of modifying triglycerides and triglyceride-rich lipoproteins on cardiovascular outcomes.
    Abdel-Maksoud M, Sazonov V, Gutkin SW, Hokanson JE.
    J Cardiovasc Pharmacol; 2008 Apr 07; 51(4):331-51. PubMed ID: 18427276
    [Abstract] [Full Text] [Related]

  • 6. [Treatment of dyslipoproteinemia risk factor. Lipid therapy must become multidimensional].
    MMW Fortschr Med; 2008 Jun 26; 150(26-27):52-3. PubMed ID: 18681233
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Dyslipidaemia in diabetes.
    Patel J.
    Clin Evid; 2006 Jun 26; (15):555-75. PubMed ID: 16973026
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Drugs for lipids.
    Treat Guidel Med Lett; 2014 Jan 26; 12(137):1-6; quiz 7-8. PubMed ID: 24419209
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Comparative effects of rosuvastatin and gemfibrozil on glucose, insulin, and lipid metabolism in insulin-resistant, nondiabetic patients with combined dyslipidemia.
    Lamendola C, Abbasi F, Chu JW, Hutchinson H, Cain V, Leary E, McLaughlin T, Stein E, Reaven G.
    Am J Cardiol; 2005 Jan 15; 95(2):189-93. PubMed ID: 15642550
    [Abstract] [Full Text] [Related]

  • 18. Beyond LDL cholesterol: the role of elevated triglycerides and low HDL cholesterol in residual CVD risk remaining after statin therapy.
    Alagona P.
    Am J Manag Care; 2009 Mar 15; 15(3 Suppl):S65-73. PubMed ID: 19355805
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.